| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |